Cybin Inc. Chief Business Officer to Speak at H.C. Wainwright Conference
Update: 2025-09-04
Description
Cybin Inc., a neuropsychiatry company, will have their Chief Business Officer participating in a fireside chat at the H.C. Wainwright 27th Annual Global Investment Conference to discuss their focus on developing new treatment options for mental health conditions, including CYB003 in Phase 3 studies for major depressive disorder and CYB004 in a Phase 2 study for generalized anxiety disorder. Established in 2019, Cybin is actively operating in Canada, the United States, the United Kingdom, and Ireland.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
